Literature DB >> 21391110

Effect of myricetin on deoxycorticosterone acetate (DOCA)-salt-hypertensive rats.

Pravin Borde1, Mahalaxmi Mohan, Sanjay Kasture.   

Abstract

Chronic administration of myricetin (100 and 300 mg kg⁻¹, p.o., for 4 weeks) isolated from Vitis vinifera (Vitaceae) ameliorated hypertension and oxidative stress induced by deoxycorticosterone acetate (DOCA)-salt in rats. Myricetin treatment reduced systolic blood pressure, vascular reactivity changes and reversed the DOCA-induced increase in heart rate. Urinary sodium excretion was significantly decreased in animals treated with myricetin compared to the DOCA group when measured by flame photometer. The cumulative concentration response curve of serotonin (5-HT) and angiotensin II (Ang II) were shifted towards the right in rats treated with myricetin using the isolated rat fundus strip and ascending colon, respectively. Increased levels of thiobarbituric acid reactive substances and decreased levels of superoxide dismutase, catalase and reduced glutathione in the heart tissue were observed in animals treated with DOCA, which were reversed by myricetin. Thus, myricetin shows antihypertensive and antioxidant properties in the DOCA model of hypertension.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21391110     DOI: 10.1080/14786410903335190

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  10 in total

1.  Resveratrol affects histone 3 lysine 27 methylation of vessels and blood biomarkers in DOCA salt-induced hypertension.

Authors:  Sevtap Han; Mecit Orhan Uludag; Suzan Emel Usanmaz; Fatma Ayaloglu-Butun; Kamil Can Akcali; Emine Demirel-Yilmaz
Journal:  Mol Biol Rep       Date:  2014-09-19       Impact factor: 2.316

2.  Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats.

Authors:  Bhupesh Sharma; Nirmal Singh
Journal:  Psychopharmacology (Berl)       Date:  2012-04-20       Impact factor: 4.530

Review 3.  Myricetin: A Dietary Molecule with Diverse Biological Activities.

Authors:  Deepak Kumar Semwal; Ruchi Badoni Semwal; Sandra Combrinck; Alvaro Viljoen
Journal:  Nutrients       Date:  2016-02-16       Impact factor: 5.717

Review 4.  Potential angiotensin converting enzyme (ACE) inhibitors from Iranian traditional plants described by Avicenna's Canon of Medicine.

Authors:  Seyede Zohre Kamrani Rad; Behjat Javadi; A Wallace Hayes; Gholamreza KarimI
Journal:  Avicenna J Phytomed       Date:  2019 Jul-Aug

5.  Interactions between Phosphatidylcholine and Kaempferol or Myristicin: Langmuir Monolayers and Microelectrophoretic Studies.

Authors:  Paulina Laszuk; Aneta D Petelska
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

Review 6.  Promising Nutritional Fruits Against Cardiovascular Diseases: An Overview of Experimental Evidence and Understanding Their Mechanisms of Action.

Authors:  Nur Zulaikha Azwa Zuraini; Mahendran Sekar; Yuan Seng Wu; Siew Hua Gan; Srinivasa Reddy Bonam; Nur Najihah Izzati Mat Rani; M Yasmin Begum; Pei Teng Lum; Vetriselvan Subramaniyan; Neeraj Kumar Fuloria; Shivkanya Fuloria
Journal:  Vasc Health Risk Manag       Date:  2021-11-23

7.  A Comparative Study of the Antihypertensive and Cardioprotective Potentials of Hot and Cold Aqueous Extracts of Hibiscus sabdariffa L. in Relation to Their Metabolic Profiles.

Authors:  Mohamed A Salem; Shahira M Ezzat; Kawkab A Ahmed; Saleh Alseekh; Alisdair R Fernie; Reham M Essam
Journal:  Front Pharmacol       Date:  2022-02-23       Impact factor: 5.810

8.  Effects of Piper sarmentosum Roxb. on hypertension and diabetes mellitus: A systematic review and meta-analysis.

Authors:  Nur Syakirah Othman; Nur Aishah Che Roos; Amilia Aminuddin; Jaya Kumar Murthy; Adila A Hamid; Azizah Ugusman
Journal:  Front Pharmacol       Date:  2022-08-25       Impact factor: 5.988

Review 9.  Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications.

Authors:  Yasaman Taheri; Hafiz Ansar Rasul Suleria; Natália Martins; Oksana Sytar; Ahmet Beyatli; Balakyz Yeskaliyeva; Gulnaz Seitimova; Bahare Salehi; Prabhakar Semwal; Sakshi Painuli; Anuj Kumar; Elena Azzini; Miquel Martorell; William N Setzer; Alfred Maroyi; Javad Sharifi-Rad
Journal:  BMC Complement Med Ther       Date:  2020-08-01

10.  Myricetin Alleviates Pathological Cardiac Hypertrophy via TRAF6/TAK1/MAPK and Nrf2 Signaling Pathway.

Authors:  Hai-Han Liao; Nan Zhang; Yan-Yan Meng; Hong Feng; Jing-Jing Yang; Wen-Jin Li; Si Chen; Hai-Ming Wu; Wei Deng; Qi-Zhu Tang
Journal:  Oxid Med Cell Longev       Date:  2019-12-06       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.